1-methyl-3-isobutylxanthine has been researched along with Small Cell Lung Carcinoma in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Small Cell Lung Carcinoma: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lange, A | 1 |
| Gustke, H | 1 |
| Glassmeier, G | 1 |
| Heine, M | 1 |
| Zangemeister-Wittke, U | 1 |
| Schwarz, JR | 1 |
| Schumacher, U | 1 |
| Lange, T | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro.
Topics: 1-Methyl-3-isobutylxanthine; CD56 Antigen; Cell Differentiation; Cell Growth Processes; Cell Line, T | 2011 |